We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
-19.31%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$1.22B
AUM Growth
-$141M
Cap. Flow
+$170M
Cap. Flow %
13.96%
Top 10 Hldgs %
19.07%
Holding
123
New
1
Increased
114
Reduced
6
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 24.25%
2 Financials 14.54%
3 Technology 12.79%
4 Healthcare 11.1%
5 Consumer Discretionary 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEFT icon
1
Euronet Worldwide
EEFT
$3.19B
$27.5M 2.25%
268,785
+1,304
+0.5% +$144K
ALE
2
DELISTED
Allete
ALE
$26.4M 2.16%
346,115
+52,161
+18% +$4.04M
NBHC icon
3
National Bank Holdings
NBHC
$1.9B
$26M 2.13%
841,241
+123,657
+17% +$4.28M
QTS
4
DELISTED
QTS REALTY TRUST, INC.
QTS
$24M 1.97%
649,045
+97,628
+18% +$3.87M
MMSI icon
5
Merit Medical Systems
MMSI
$4.82B
$23.9M 1.96%
429,134
+5,011
+1% +$298K
MNRO icon
6
Monro
MNRO
$415M
$22.1M 1.81%
322,162
+48,471
+18% +$3.54M
EPAY
7
DELISTED
Bottomline Technologies Inc
EPAY
$21.7M 1.78%
452,299
+15,893
+4% +$919K
HMSY
8
DELISTED
HMS Holdings Corp.
HMSY
$21.7M 1.78%
770,940
+115,336
+18% +$3.73M
HLF icon
9
Herbalife
HLF
$1.3B
$20.2M 1.65%
342,430
+32,227
+10% +$1.78M
CRI icon
10
Carter's
CRI
$1.43B
$19.2M 1.57%
234,654
+36,203
+18% +$3.29M
EFOR
11
Everforth Inc
EFOR
$960M
$19M 1.56%
349,257
+52,409
+18% +$3.42M
AER icon
12
AerCap
AER
$23.4B
$18.7M 1.54%
473,368
+70,342
+17% +$3.52M
FLWS icon
13
1-800-Flowers.com
FLWS
$252M
$18.7M 1.53%
1,527,170
+162,371
+12% +$1.94M
GWR
14
DELISTED
Genesee & Wyoming Inc.
GWR
$18.4M 1.51%
249,173
+37,079
+17% +$2.97M
MRCY icon
15
Mercury Systems
MRCY
$5.41B
$18.3M 1.5%
386,303
+35,495
+10% +$1.73M
CHE icon
16
Chemed
CHE
$7.16B
$18M 1.47%
63,504
+9,812
+18% +$2.96M
ITRI icon
17
Itron
ITRI
$4.48B
$17.1M 1.4%
361,229
+69,029
+24% +$3.65M
AIN icon
18
Albany International
AIN
$2.09B
$16.7M 1.37%
267,513
+40,360
+18% +$2.82M
WWE
19
DELISTED
World Wrestling Entertainment
WWE
$16.7M 1.37%
223,029
-10,031
-4% -$753K
EFII
20
DELISTED
Electronics for Imaging
EFII
$16.5M 1.35%
663,815
+100,322
+18% +$2.89M
B
21
DELISTED
Barnes Group Inc.
B
$16.4M 1.34%
305,304
+33,748
+12% +$1.98M
CRL icon
22
Charles River Laboratories
CRL
$11.3B
$16.3M 1.34%
144,223
+18,271
+15% +$2.29M
ACIW icon
23
ACI Worldwide
ACIW
$6.12B
$16M 1.31%
579,552
+85,673
+17% +$2.32M
IWM icon
24
iShares Russell 2000 ETF
IWM
$79.1B
$15.5M 1.27%
115,572
+24,902
+27% +$3.72M
DY icon
25
Dycom Industries
DY
$11.2B
$15M 1.23%
278,435
+41,729
+18% +$2.8M

Similar funds

Aristotle Capital Boston's Q4 2018 Portfolio in Review

As of Q4 2018, Aristotle Capital Boston held 123 positions worth $1.22B, down 10% from $1.36B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Aristotle Capital Boston deployed $170M of net new capital in Q4 2018, opening 1 new position and adding to 114 existing holdings. Its largest new stake was MACOM Technology Solutions: 413,464 shares worth $6M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Hannon Armstrong Sustainable Infrastructure Capital, an estimated $4.92M trimmed.

  • Aristotle Capital Boston's largest Q4 2018 buy was MACOM Technology Solutions: 413,464 shares worth $6M.
  • Aristotle Capital Boston added most to National Bank Holdings in Q4 2018, an estimated $4.28M increase.
  • Aristotle Capital Boston's biggest Q4 2018 reduction was Hannon Armstrong Sustainable Infrastructure Capital, cutting an estimated $4.92M.
  • Aristotle Capital Boston fully exited Envision Healthcare Holdings Inc in Q4 2018, selling an estimated $19.2M.
  • Aristotle Capital Boston's ten largest holdings make up 19% of its $1.22B portfolio in Q4 2018.
  • Aristotle Capital Boston opened 1 new position and closed 2 in Q4 2018.
  • Aristotle Capital Boston's portfolio value fell 10% quarter-over-quarter to $1.22B.

Based on Aristotle Capital Boston's 13F filing for Q4 2018, filed 13 Feb 2019.